NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD (NSB)

---

AI Coverage Rating: Low

ASX AI Signals has generated 0 signals for NSB during the last 90 days, indicating low trading activity

NSB Share Price
Current Price	$0.064
52 Week High	$0.250
52 Week Low:	$0.059
Trading at (% of 52 Week High)	25.60%

Business Overview

Neuroscientific Biopharmaceuticals Ltd (ASX: NSB) is a biotechnology company focused on developing treatments for brain diseases, including brain cancer and traumatic brain injury. The company works on advancing its drug candidates through research and clinical trials to address neurological conditions.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The SELL recommendation for NSB is supported by weak price performance and potential sector volatility, indicating a high likelihood of continued downside risk. However, limited liquidity and market capitalization introduce some uncertainty, moderating the confidence level.

Latest  NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD(NSB)   News